Article(id=1326652866124690123, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652739800642340, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.05.007, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1732291200000, receivedDateStr=2024-11-23, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228291301, onlineDateStr=2026-11-09, pubDate=1746806400000, pubDateStr=2025-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228291301, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228291301, creator=13701087609, updateTime=1794228291301, updator=13701087609, issue=Issue{id=1326652739800642340, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='5', pageStart='429', pageEnd='528', issueExtLink='null', onlineDate='null', pubDate='1746806400000', pubDateStr='2025-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228261184, creator='13701087609', updateTime=1794273040769, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840559311893443, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652739800642340, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840559311893444, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652739800642340, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=465, endPage=470, ext={EN=ArticleExt(id=1326652867965989581, articleId=1326652866124690123, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Budget impact analysis of nivolumab and ipilimumab for the treatment of unresectable malignant pleural mesothelioma, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To evaluate the budget impact of the combination therapy of nivolumab and ipilimumab for the treatment of unresectable malignant pleural mesothelioma after its inclusion in the China's National Reimbuirsement Drug List (NRDL).

Methods

This study constructed a 5-year (2024—2028) budget impact analysis model from the perspective of the Chinese government health insurance authority to simulate the budget changes after the combination therapy of nivolumab and ipilimumab was included in the NRDL. The model analyzed factors such as the target population, drug market share, and treatment costs, comparing healthcare expenditures in scenarios with and without insurance coverage.One-way sensitivity analysis was performed to assess model robustness.

Results

After inclusion in the NRDL, the incremental expenditure from 2024 to 2028 mainly stems from health insurance payment portion of drug costs, with a cumulative increase of 66.645 million yuan. However, the overall financial impact on the insurance fund remains minimal.Sensitivity analysis showed that drug prices, reimbursement rates, and insurance coverage rates were the key factors affecting budget changes.

Conclusion

Although the combination therapy of nivolumab and ipilimumab included in the NRDL will increase expenditure, the impact on the overall fund burden is limited.

, authors=Yun YANG1, Na ZHAO2, Yan XU3, Yang ZHAO3, *, authorsList=Yun YANG, Na ZHAO, Yan XU, Yang ZHAO, authorCompany=null, correspAuthors=Yang ZHAO, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326652868242813646, articleId=1326652866124690123, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=纳武利尤单抗联合伊匹木单抗用于治疗不可手术切除恶性胸膜间皮瘤的预算影响分析, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

分析纳武利尤单抗与伊匹木单抗联合治疗不可手术切除的恶性胸膜间皮瘤纳入中国国家医保目录后的预算影响。

方法

基于医保支付方视角,建立5年(2024—2028年)预算影响分析模型,预测该联合疗法纳入医保后的预算变化。研究通过目标人群规模、药物市场份额及治疗成本等参数,对比纳入与未纳入医保两种情境下的医保支出差异,并采用单因素敏感性分析验证模型稳健性。

结果

纳入医保后,2024—2028年医保基金累计支出增加6 664.5万元,主要源于药品费用的医保支付部分,但对基金总体负担影响有限。敏感性分析表明,药品价格、医保报销比例及覆盖率是预算变化的关键驱动因素。

结论

尽管该疗法纳入医保会增加医保支出,但其对基金整体压力影响可控。

, authors=杨运1, 赵娜2, 徐燕3, 赵杨3, *, authorsList=杨运, 赵娜, 徐燕, 赵杨, authorCompany=null, correspAuthors=赵杨, authorNote=

杨运,主管药师,研究方向:药品政策和医保支付管理政策研究。

, correspAuthorsNote=
赵杨,主任药师,研究方向:药品政策和药物经济学研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=aZh78FAHwg2PBBpMMcNY0w==, magXml=0ngQxI+ocdOC5l01aXSYow==, pdfUrl=null, pdf=nRE6tUrKTHKGg5BL1srNeg==, pdfFileSize=927351, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=5XR/+2b+CmrRR6TbyZgkrw==, mapNumber=null, fund=null)}, authors=[Author(id=1326652868758713049, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652868842599131, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652868758713049, language=EN, stringName=Yun YANG, firstName=Yun, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Henan Medical Price and Bidding Procurement Service Center, Zhengzhou 450000; Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652868922290908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652868758713049, language=CN, stringName=杨运, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.河南省医药价格和招标采购服务中心,河南 郑州 450000, bio={"content":"

杨运,主管药师,研究方向:药品政策和医保支付管理政策研究。

"}, bioImg=null, bioContent=

杨运,主管药师,研究方向:药品政策和医保支付管理政策研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652868486083279, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=1., ext=[AuthorCompanyExt(id=1326652868494471888, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868486083279, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Henan Medical Price and Bidding Procurement Service Center, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868507054801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868486083279, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河南省医药价格和招标采购服务中心,河南 郑州 450000)])]), Author(id=1326652868985205470, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652869060702944, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652868985205470, language=EN, stringName=Na ZHAO, firstName=Na, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Henan Medical College, Zhengzhou 450000; Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652869111034593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652868985205470, language=CN, stringName=赵娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.河南医学高等专科学校,河南 郑州 450000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652868578357970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=2., ext=[AuthorCompanyExt(id=1326652868590940883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868578357970, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Henan Medical College, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868599329492, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868578357970, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河南医学高等专科学校,河南 郑州 450000)])]), Author(id=1326652869178143459, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652869241058021, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652869178143459, language=EN, stringName=Yan XU, firstName=Yan, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000; Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652869299778278, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652869178143459, language=CN, stringName=徐燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.郑州大学第五附属医院,河南 郑州 450000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652868674826965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=3., ext=[AuthorCompanyExt(id=1326652868683215574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868674826965, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868691604183, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868674826965, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.郑州大学第五附属医院,河南 郑州 450000)])]), Author(id=1326652869354304232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652869421413098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652869354304232, language=EN, stringName=Yang ZHAO, firstName=Yang, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000; Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652869522076395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652869354304232, language=CN, stringName=赵杨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.郑州大学第五附属医院,河南 郑州 450000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652868674826965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=3., ext=[AuthorCompanyExt(id=1326652868683215574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868674826965, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868691604183, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868674826965, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.郑州大学第五附属医院,河南 郑州 450000)])])], keywords=[Keyword(id=1326652869597573868, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=EN, orderNo=1, keyword=malignant pleural mesothelioma), Keyword(id=1326652869673071341, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=EN, orderNo=2, keyword=budget impact analysis), Keyword(id=1326652869727597294, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=EN, orderNo=3, keyword=nivolumab), Keyword(id=1326652869786317551, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=EN, orderNo=4, keyword=ipilimumab), Keyword(id=1326652869845037808, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=EN, orderNo=5, keyword=insurance reimbursement), Keyword(id=1326652869912146673, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=EN, orderNo=6, keyword=National Reimbuirsement Drug List), Keyword(id=1326652870008615666, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=CN, orderNo=1, keyword=恶性胸膜间皮瘤), Keyword(id=1326652870067335923, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=CN, orderNo=2, keyword=预算影响分析), Keyword(id=1326652870126056180, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=CN, orderNo=3, keyword=纳武利尤单抗), Keyword(id=1326652870193165045, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=CN, orderNo=4, keyword=伊匹木单抗), Keyword(id=1326652870243496694, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=CN, orderNo=5, keyword=医保报销), Keyword(id=1326652870318994167, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, language=CN, orderNo=6, keyword=国家医保药品目录)], refs=[Reference(id=1326652870398685944, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=CARTENI G, MANEGOLD C, GARCIA GM, et al.Malignant peritoneal mesothelioma - Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent[J]. Lung Cancer, 2009, 64(2): 211-218., articleTitle=null, refAbstract=null), Reference(id=1326652870474183417, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=TAIOLI E, WOLF AS, CAMACHO-RIVERA M, et al.Determinants of survival in malignant pleural mesothelioma:a surveillance, epidemiology, and end results(SEER) study of 14 228 patients[J]. PLoS One, 2015, 10(12): e0145039., articleTitle=null, refAbstract=null), Reference(id=1326652870541292282, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=SUNG H, FERLAY J, SIEGEL RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249., articleTitle=null, refAbstract=null), Reference(id=1326652870608401147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=赫捷, 魏文强. 2019 中国肿瘤登记年报[M]. 北京: 人民卫生出版社, 2021., articleTitle=null, refAbstract=null), Reference(id=1326652870683898620, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=中国医师协会肿瘤多学科诊疗专业委员会. 中国恶性胸膜间皮瘤临床诊疗指南(2021 版)[J]. 中华肿瘤杂志, 2021,43(4): 383-394., articleTitle=null, refAbstract=null), Reference(id=1326652872361620221, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=BAAS P, SCHERPEREEL A, NOWAK AK, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised,open-label, phase 3 trial[J]. Lancet, 2021, 397(10272): 375-386., articleTitle=null, refAbstract=null), Reference(id=1326652872453894910, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=U.S. Food and Drug Administration. FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma[EB/OL]. (2020-10-02)[2024-09-15]. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-nivolumab-and-ipilimumab-unresectable-malignant-pleural-mesothelioma., articleTitle=null, refAbstract=null), Reference(id=1326652872533586687, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Canadian Medical Association. Nivolumab with ipilimumab for untreated cancer [EB/OL]. (2021-08-04) [2024-09-15].https://www.cda-amc.ca/nivolumab-ipilimumab., articleTitle=null, refAbstract=null), Reference(id=1326652872596501248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=European Medicines Agency. Opdivo EPAR[EB/OL].(2024-04-26)[2024-09-15]. https://www.ema.europa.eu/en/medicines/human/EPAR/opdivo., articleTitle=null, refAbstract=null), Reference(id=1326652872667804417, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=National Institute for Health and Care Excellence.Nivolumab with ipilimumab for untreated malignant pleural mesothelioma[EB/OL]. (2022-08-17)[2024-09-15]. https://www.nice.org.uk/guidance/TA818., articleTitle=null, refAbstract=null), Reference(id=1326652872739107586, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=药品中标数据库[DB/OL]. (2024-10-14)[2024-09-15].https://db.yaozh.com/yaopinzhongbiao., articleTitle=null, refAbstract=null), Reference(id=1326652872814605059, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=MAUSKOPF JA, EARNSHAW S, MULLINS CD. Budget impact analysis: review of the state of the art[J]. Expert Rev Pharmacoecon Outcomes Res, 2005, 5(1): 65-79., articleTitle=null, refAbstract=null), Reference(id=1326652872894296836, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=国家统计局. 中华人民共和国 2023 年国民经济和社会发展统计公报[EB/OL]. (2024-02-29)[2024-09-15]. https://www.stats.gov.cn/sj/zxfb/202402/t20240228_1947915.html., articleTitle=null, refAbstract=null), Reference(id=1326652872978182917, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAI Y, HUI Z, CHEN W, et al. The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016-2030[J]. Transl Lung Cancer Res, 2022, 11(12): 2403-2411., articleTitle=null, refAbstract=null), Reference(id=1326652873049486086, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=MAO W, ZHANG X, GUO Z, et al. Association of asbestos exposure with malignant mesothelioma incidence in Eastern China[J]. J Am Med Assoc Oncol, 2017, 3(4): 562-564., articleTitle=null, refAbstract=null), Reference(id=1326652873129177863, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=邵荣杰, 唐文熙, 徐赫, 等. 帕博利珠单抗用于治疗经一线治疗失败的不可切除或转移性黑色素瘤的预算影响分析[J]. 中国药物评价, 2020, 37(2): 148-152., articleTitle=null, refAbstract=null), Reference(id=1326652873213063944, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=郭娅, 文海棠, 谢又佳, 等. 帕博利珠单抗治疗 EGFR 基因突变阴性和 ALK 阴性的晚期或转移性非小细胞肺癌的预算影响分析[J]. 中国药房, 2024, 35(17): 2114-2119., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1326652868486083279, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=1., ext=[AuthorCompanyExt(id=1326652868494471888, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868486083279, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Henan Medical Price and Bidding Procurement Service Center, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868507054801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868486083279, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河南省医药价格和招标采购服务中心,河南 郑州 450000)]), AuthorCompany(id=1326652868578357970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=2., ext=[AuthorCompanyExt(id=1326652868590940883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868578357970, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Henan Medical College, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868599329492, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868578357970, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河南医学高等专科学校,河南 郑州 450000)]), AuthorCompany(id=1326652868674826965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=3., ext=[AuthorCompanyExt(id=1326652868683215574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868674826965, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868691604183, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868674826965, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.郑州大学第五附属医院,河南 郑州 450000)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.05.007, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.05.007, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.05.007, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.05.007, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1746806400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
纳武利尤单抗联合伊匹木单抗用于治疗不可手术切除恶性胸膜间皮瘤的预算影响分析
杨运 1 , 赵娜 2 , 徐燕 3 , 赵杨 3, *
世界临床药物 | 研究论文 2025,46(5): 465-470
收起
收藏切换
世界临床药物 |研究论文 2025 , 46 (5) : 465 -470
纳武利尤单抗联合伊匹木单抗用于治疗不可手术切除恶性胸膜间皮瘤的预算影响分析
全屏
[Author(id=1326652868758713049, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652868842599131, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652868758713049, language=EN, stringName=Yun YANG, firstName=Yun, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Henan Medical Price and Bidding Procurement Service Center, Zhengzhou 450000; Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652868922290908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652868758713049, language=CN, stringName=杨运, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.河南省医药价格和招标采购服务中心,河南 郑州 450000, bio={"content":"

杨运,主管药师,研究方向:药品政策和医保支付管理政策研究。

"}, bioImg=null, bioContent=

杨运,主管药师,研究方向:药品政策和医保支付管理政策研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652868486083279, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=1., ext=[AuthorCompanyExt(id=1326652868494471888, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868486083279, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Henan Medical Price and Bidding Procurement Service Center, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868507054801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868486083279, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河南省医药价格和招标采购服务中心,河南 郑州 450000)])]), Author(id=1326652868985205470, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652869060702944, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652868985205470, language=EN, stringName=Na ZHAO, firstName=Na, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Henan Medical College, Zhengzhou 450000; Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652869111034593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652868985205470, language=CN, stringName=赵娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.河南医学高等专科学校,河南 郑州 450000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652868578357970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=2., ext=[AuthorCompanyExt(id=1326652868590940883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868578357970, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Henan Medical College, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868599329492, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868578357970, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河南医学高等专科学校,河南 郑州 450000)])]), Author(id=1326652869178143459, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652869241058021, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652869178143459, language=EN, stringName=Yan XU, firstName=Yan, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000; Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652869299778278, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652869178143459, language=CN, stringName=徐燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.郑州大学第五附属医院,河南 郑州 450000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652868674826965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=3., ext=[AuthorCompanyExt(id=1326652868683215574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868674826965, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868691604183, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868674826965, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.郑州大学第五附属医院,河南 郑州 450000)])]), Author(id=1326652869354304232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652869421413098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652869354304232, language=EN, stringName=Yang ZHAO, firstName=Yang, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000; Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652869522076395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, authorId=1326652869354304232, language=CN, stringName=赵杨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.郑州大学第五附属医院,河南 郑州 450000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652868674826965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, xref=3., ext=[AuthorCompanyExt(id=1326652868683215574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868674826965, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000; Henan Province, China), AuthorCompanyExt(id=1326652868691604183, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652866124690123, companyId=1326652868674826965, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.郑州大学第五附属医院,河南 郑州 450000)])])]
杨运1, 赵娜2, 徐燕3, 赵杨3, *
作者信息
  • 1.河南省医药价格和招标采购服务中心,河南 郑州 450000
  • 2.河南医学高等专科学校,河南 郑州 450000
  • 3.郑州大学第五附属医院,河南 郑州 450000
通讯作者:
赵杨,主任药师,研究方向:药品政策和药物经济学研究。
作者简介:

杨运,主管药师,研究方向:药品政策和医保支付管理政策研究。

Budget impact analysis of nivolumab and ipilimumab for the treatment of unresectable malignant pleural mesothelioma
Yun YANG1, Na ZHAO2, Yan XU3, Yang ZHAO3, *
Affiliations
  • 1.Henan Medical Price and Bidding Procurement Service Center, Zhengzhou 450000; Henan Province, China
  • 2.Henan Medical College, Zhengzhou 450000; Henan Province, China
  • 3.Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000; Henan Province, China
出版时间: 2025-05-10 doi: 10.13683/j.wph.2025.05.007
文章导航
收藏切换
目的

分析纳武利尤单抗与伊匹木单抗联合治疗不可手术切除的恶性胸膜间皮瘤纳入中国国家医保目录后的预算影响。

方法

基于医保支付方视角,建立5年(2024—2028年)预算影响分析模型,预测该联合疗法纳入医保后的预算变化。研究通过目标人群规模、药物市场份额及治疗成本等参数,对比纳入与未纳入医保两种情境下的医保支出差异,并采用单因素敏感性分析验证模型稳健性。

结果

纳入医保后,2024—2028年医保基金累计支出增加6 664.5万元,主要源于药品费用的医保支付部分,但对基金总体负担影响有限。敏感性分析表明,药品价格、医保报销比例及覆盖率是预算变化的关键驱动因素。

结论

尽管该疗法纳入医保会增加医保支出,但其对基金整体压力影响可控。

恶性胸膜间皮瘤  /  预算影响分析  /  纳武利尤单抗  /  伊匹木单抗  /  医保报销  /  国家医保药品目录
Objective

To evaluate the budget impact of the combination therapy of nivolumab and ipilimumab for the treatment of unresectable malignant pleural mesothelioma after its inclusion in the China's National Reimbuirsement Drug List (NRDL).

Methods

This study constructed a 5-year (2024—2028) budget impact analysis model from the perspective of the Chinese government health insurance authority to simulate the budget changes after the combination therapy of nivolumab and ipilimumab was included in the NRDL. The model analyzed factors such as the target population, drug market share, and treatment costs, comparing healthcare expenditures in scenarios with and without insurance coverage.One-way sensitivity analysis was performed to assess model robustness.

Results

After inclusion in the NRDL, the incremental expenditure from 2024 to 2028 mainly stems from health insurance payment portion of drug costs, with a cumulative increase of 66.645 million yuan. However, the overall financial impact on the insurance fund remains minimal.Sensitivity analysis showed that drug prices, reimbursement rates, and insurance coverage rates were the key factors affecting budget changes.

Conclusion

Although the combination therapy of nivolumab and ipilimumab included in the NRDL will increase expenditure, the impact on the overall fund burden is limited.

malignant pleural mesothelioma  /  budget impact analysis  /  nivolumab  /  ipilimumab  /  insurance reimbursement  /  National Reimbuirsement Drug List
杨运, 赵娜, 徐燕, 赵杨. 纳武利尤单抗联合伊匹木单抗用于治疗不可手术切除恶性胸膜间皮瘤的预算影响分析. 世界临床药物, 2025 , 46 (5) : 465 -470 . DOI: 10.13683/j.wph.2025.05.007
Yun YANG, Na ZHAO, Yan XU, Yang ZHAO. Budget impact analysis of nivolumab and ipilimumab for the treatment of unresectable malignant pleural mesothelioma[J]. World Clinical Drug, 2025 , 46 (5) : 465 -470 . DOI: 10.13683/j.wph.2025.05.007

参考文献 引证文献
排序方式:
[1]
CARTENI G, MANEGOLD C, GARCIA GM, et al.Malignant peritoneal mesothelioma - Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent[J]. Lung Cancer, 2009, 64(2): 211-218.
[2]
TAIOLI E, WOLF AS, CAMACHO-RIVERA M, et al.Determinants of survival in malignant pleural mesothelioma:a surveillance, epidemiology, and end results(SEER) study of 14 228 patients[J]. PLoS One, 2015, 10(12): e0145039.
[3]
SUNG H, FERLAY J, SIEGEL RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[4]
赫捷, 魏文强. 2019 中国肿瘤登记年报[M]. 北京: 人民卫生出版社, 2021.
[5]
中国医师协会肿瘤多学科诊疗专业委员会. 中国恶性胸膜间皮瘤临床诊疗指南(2021 版)[J]. 中华肿瘤杂志, 2021,43(4): 383-394.
[6]
BAAS P, SCHERPEREEL A, NOWAK AK, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised,open-label, phase 3 trial[J]. Lancet, 2021, 397(10272): 375-386.
[7]
U.S. Food and Drug Administration. FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma[EB/OL]. (2020-10-02)[2024-09-15]. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-nivolumab-and-ipilimumab-unresectable-malignant-pleural-mesothelioma.
[8]
Canadian Medical Association. Nivolumab with ipilimumab for untreated cancer [EB/OL]. (2021-08-04) [2024-09-15].https://www.cda-amc.ca/nivolumab-ipilimumab.
[9]
European Medicines Agency. Opdivo EPAR[EB/OL].(2024-04-26)[2024-09-15]. https://www.ema.europa.eu/en/medicines/human/EPAR/opdivo.
[10]
National Institute for Health and Care Excellence.Nivolumab with ipilimumab for untreated malignant pleural mesothelioma[EB/OL]. (2022-08-17)[2024-09-15]. https://www.nice.org.uk/guidance/TA818.
[11]
药品中标数据库[DB/OL]. (2024-10-14)[2024-09-15].https://db.yaozh.com/yaopinzhongbiao.
[12]
MAUSKOPF JA, EARNSHAW S, MULLINS CD. Budget impact analysis: review of the state of the art[J]. Expert Rev Pharmacoecon Outcomes Res, 2005, 5(1): 65-79.
[13]
国家统计局. 中华人民共和国 2023 年国民经济和社会发展统计公报[EB/OL]. (2024-02-29)[2024-09-15]. https://www.stats.gov.cn/sj/zxfb/202402/t20240228_1947915.html.
[14]
ZHAI Y, HUI Z, CHEN W, et al. The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016-2030[J]. Transl Lung Cancer Res, 2022, 11(12): 2403-2411.
[15]
MAO W, ZHANG X, GUO Z, et al. Association of asbestos exposure with malignant mesothelioma incidence in Eastern China[J]. J Am Med Assoc Oncol, 2017, 3(4): 562-564.
[16]
邵荣杰, 唐文熙, 徐赫, 等. 帕博利珠单抗用于治疗经一线治疗失败的不可切除或转移性黑色素瘤的预算影响分析[J]. 中国药物评价, 2020, 37(2): 148-152.
[17]
郭娅, 文海棠, 谢又佳, 等. 帕博利珠单抗治疗 EGFR 基因突变阴性和 ALK 阴性的晚期或转移性非小细胞肺癌的预算影响分析[J]. 中国药房, 2024, 35(17): 2114-2119.
2025年第46卷第5期
55
11
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.05.007
  • 接收时间:2024-11-23
  • 首发时间:2026-11-09
  • 出版时间:2025-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-11-23
基金
作者信息
    1.河南省医药价格和招标采购服务中心,河南 郑州 450000
    2.河南医学高等专科学校,河南 郑州 450000
    3.郑州大学第五附属医院,河南 郑州 450000

通讯作者:

赵杨,主任药师,研究方向:药品政策和药物经济学研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.05.007
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏